Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05680675 · ClinicalTrials.gov registry record · NA

Dual-Tracer Theranostic PET

A NA study of Prostate Cancer and Neuroendocrine Tumors, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05680675 is a NA study of Prostate Cancer and Neuroendocrine Tumors that has completed, run by University of Utah. The registered enrollment target is 50 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05680675, a NA study of Prostate Cancer and Neuroendocrine Tumors, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study is designed to obtain positron emission tomography with x-ray computed tomography (PET/CT) imaging data with each tracer pair, providing the imaging data needed to develop new simultaneous dual-tracer imaging techniques and processing algorithms for these tracer pairs.

Conditions Studied

Prostate Cancer Neuroendocrine Tumors

Interventions

  • DIAGNOSTIC_TEST Single-Tracer FDG PET/CT Exam
  • DIAGNOSTIC_TEST Single-Tracer Cu64-DOTATATE PET/CT Exam
  • DIAGNOSTIC_TEST Single-Tracer Ga68-DOTATATE PET/CT Exam
  • DIAGNOSTIC_TEST Single-Tracer PSMA PET/CT Exam

Study Locations (1)

Utah

  • Huntsman Cancer Institute - Salt Lake City

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-12-08
Est. Completion 2024-06-04
Phase NA

Sponsor

University of Utah

818 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05680675

The ClinicalTrials.gov registry entry for NCT05680675 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 4 interventions - of which Single-Tracer FDG PET/CT Exam is the first listed.

NCT05680675 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT05680675 about?

NCT05680675 is a clinical study titled "Dual-Tracer Theranostic PET". This study is designed to obtain positron emission tomography with x-ray computed tomography (PET/CT) imaging data with each tracer pair, providing the imaging data needed to develop new simultaneous dual-tracer imaging techniques and processing algorithms for these tracer pairs.

What is the current status of trial NCT05680675?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-12-08. Estimated completion is 2024-06-04.

What conditions does trial NCT05680675 study?

This clinical trial studies the following conditions: Prostate Cancer, Neuroendocrine Tumors.

What interventions are being tested in trial NCT05680675?

The interventions under investigation include: Single-Tracer FDG PET/CT Exam (DIAGNOSTIC_TEST), Single-Tracer Cu64-DOTATATE PET/CT Exam (DIAGNOSTIC_TEST), Single-Tracer Ga68-DOTATATE PET/CT Exam (DIAGNOSTIC_TEST), Single-Tracer PSMA PET/CT Exam (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05680675?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05680675 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Neuroendocrine Tumors

All registered trials for this condition

Utah

All trials with a study site in Utah

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.